U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07643792) titled 'Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Fracture Surgery' on June 07.
Brief Summary: Older patients with hip fractures often suffer from severe pain. Inadequate analgesia increases the risk of postoperative delirium, myocardial injury, and other complications. Peripheral nerve block is an important component of multimodal analgesia, but conventional local anesthetics (e.g., plain bupivacaine) provide only approximately 12 hours of analgesic duration, which is far from covering the most painful 72 hours after surgery. Liposomal bupivacaine has a slow-release property, prolonging the analgesic duration ...